Citius Pharmaceuticals Inc
NASDAQ:CTXR

Watchlist Manager
Citius Pharmaceuticals Inc Logo
Citius Pharmaceuticals Inc
NASDAQ:CTXR
Watchlist
Price: 0.8408 USD 5.1% Market Closed
Market Cap: 14.3m USD

Intrinsic Value

The intrinsic value of one CTXR stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.8408 USD, Citius Pharmaceuticals Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

CTXR Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case
Compare CTXR to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CTXR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Citius Pharmaceuticals Inc

Current Assets 24.6m
Cash & Short-Term Investments 6.1m
Other Current Assets 18.5m
Non-Current Assets 103.1m
PP&E 880.7k
Intangibles 102.1m
Other Non-Current Assets 38.1k
Current Liabilities 51.8m
Accounts Payable 10.1m
Accrued Liabilities 12.3m
Short-Term Debt 1m
Other Current Liabilities 28.4m
Non-Current Liabilities 10.8m
Other Non-Current Liabilities 10.8m
Efficiency

Free Cash Flow Analysis
Citius Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Citius Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-41.1m USD
Operating Income
-41.1m USD
Other Expenses
-386.3k USD
Net Income
-41.5m USD
Fundamental Scores

CTXR Profitability Score
Profitability Due Diligence

Citius Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
hidden
Profitability
Score

Citius Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CTXR Solvency Score
Solvency Due Diligence

Citius Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

Citius Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CTXR Price Targets Summary
Citius Pharmaceuticals Inc

Wall Street analysts forecast CTXR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTXR is 5.1 USD with a low forecast of 4.04 USD and a high forecast of 6.3 USD.

Lowest
Price Target
4.04 USD
380% Upside
Average
Price Target
5.1 USD
507% Upside
Highest
Price Target
6.3 USD
649% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Citius Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CTXR is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CTXR Insider Trading
Buy and sell transactions by insiders